Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 10

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 10
---
 |     | $     |
| Underwriter               
 discounts(2)              |     | $         |     | $     |
| Proceeds                  
 to us, before expenses(3) |     | $         |     | $     |

| (1) | Initial public offering                                                                                                              
 price per share is assumed at $[●] per Class A Ordinary Share, which is the midpoint of the range set forth on the cover page        
 of this prospectus. The table above assumes that the underwriters do not exercise their over-allotment option. For more information, 
 see “Underwriting” beginning on page 129 of this prospectus.                                                                         |

| (2) | An underwriting                                                                       
 discount equal to [●]% of the public offering price will be provided to underwriters. |

| (3) | Living Homeopathy expects                                                                                                          
 its cash expenses for this offering (including cash expenses payable to its underwriter for the underwriter’s out-of-pocket        
 expenses) not to exceed $[●]. For a detailed description of the compensation to be received by the underwriter, see “Underwriting” 
 beginning on page 129 of this prospectus.                                                                                          |

This offering is being conducted on a firm commitment basis. The underwriter is obligated to take and pay for all of the Class A Ordinary Shares if any such Class A Ordinary Shares are taken. Assuming an offering price of $[●] per Ordinary Share, which is the midpoint of the range set forth on the cover page of this prospectus, the total gross proceeds to Living Homeopathy, before underwriting discounts and expenses, will be $[●].

[We have granted the underwriters an option, exercisable for 45 days following the effective date of this prospectus, to purchase up to an additional [●]% of the Class A Ordinary Shares offered in this offering on the same terms to cover over-allotments, if any.]

The underwriter expects
to deliver the Class A Ordinary Shares to purchasers in the offering on or about [●], 20[25].

Living Homeopathy may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any amendments or supplements carefully before you make your investment decision.

Neither the United States Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>U